Fosamax
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
—Fosamax (Alendronate) is an approved drug widely prescribed for osteoporosis treatment and other bone damaging diseases. Fosamax…
Paget disease in clinical practice is rare. By its nature the disease represents the disorder of bone remodeling processes. The…
Objective Studying the treating effect on postmenopausal lower bone mineral density by using traditional Chinese medicine(pigeon…
Objective:To evaluate the short and long term effects and safety of HRT plus Fosamax or Fosamax on bone mineral density in…
The 10-year half-life of the bisphosphonate alendronate suggests that its efficacy might persist after discontinuation. To…
A 10-year study of daily oral alendronate (Fosamax) and a 7-year study of daily oral risedronate (Actonel) indicate that both…
Objective To evaluate the short-and long-term effects of Fosamax on bone mineral density in postmenopausal women with primary…
Data are submitted on results of investigations designed to study mineral density of the osseous tissue in patients with…